US regulator approves limited use of malaria drugs for virus

A limited emergency-use authorization for two antimalarial drugs touted as game-changers by US President Donald Trump has been issued by the US Food and Drug Administration to treat coronavirus patients.

In a statement published yesterday, the US Department of Health and Human Services details recent donations of medicine to a national stockpile — including chloroquine and hydroxychloroquine, both being investigated as potential COVID-19 treatments.

It says the FDA had allowed them “to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.”


Never miss breaking news on Israel
Get notifications to stay updated
You're subscribed